| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Baumer S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$10.49 |
| 52 Week High | R$11.98 |
| 52 Week Low | R$9.00 |
| Beta | 0.45 |
| 1 Month Change | 0% |
| 3 Month Change | 5.85% |
| 1 Year Change | 10.42% |
| 3 Year Change | -35.01% |
| 5 Year Change | -19.18% |
| Change since IPO | 3,403.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| BALM4 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 0.2% | 1.4% | -0.6% |
| 1Y | 10.4% | 0.4% | 9.0% |
Return vs Industry: BALM4 exceeded the BR Medical Equipment industry which returned 0.9% over the past year.
Return vs Market: BALM4 exceeded the BR Market which returned 8.6% over the past year.
Price Volatility
| BALM4 volatility | |
|---|---|
| BALM4 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 9.5% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: BALM4 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BALM4's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | n/a | Ruy Salvari Baumer | www.baumer.com.br |
Baumer S.A. develops solutions for health industry in Brazil. It offers environment monitor, an electronic system that monitors particles suspended in air PM10 and PM2.5, which includes temperature, relative humidity, concentration of carbon dioxide and chemical pollutants, environmental noise intensity, lighting conditions, presence of people and animals, and relative pressure. The company also provides Purafog, a web and dry nebulization; PuraVac; mini purifies; and dental solutions, such as bone graft and membrane solutions.
Baumer S.A. Fundamentals Summary
| BALM4 fundamental statistics | |
|---|---|
| Market cap | R$102.69m |
| Earnings (TTM) | R$9.98m |
| Revenue (TTM) | R$167.54m |
10.3x
P/E Ratio0.6x
P/S RatioIs BALM4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BALM4 income statement (TTM) | |
|---|---|
| Revenue | R$167.54m |
| Cost of Revenue | R$65.07m |
| Gross Profit | R$102.47m |
| Other Expenses | R$92.49m |
| Earnings | R$9.98m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.02 |
| Gross Margin | 61.16% |
| Net Profit Margin | 5.96% |
| Debt/Equity Ratio | 12.7% |
How did BALM4 perform over the long term?
See historical performance and comparison